Torrent Pharma Q2 PAT up just 2% to Rs 316 cr on drop in US sales

Overall revenues up 6% YoY, while those in US dropped by as much as 13%

Dragged by a fall in its US sales, Torrent Pharma Ltd. saw its profit after tax (PAT) for the second quarter ended September 30, 2021 rise marginally by two per cent on a year-on-year (YoY) basis to stand at Rs 316 crore for the current financial year 2021-22. Last year, the company had registered a PAT of Rs 310 crore for Q2 of financial year 2020-21.

The company's revenues grew by six per cent YoY to Rs 2,137 crore in Q2FY22, from Rs 2,017 crore in Q2FY21. In terms of geographies, while its India business grew by 13 per cent